StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2015 it was $93.11K.

Annual r&d expenses

PeriodPeriod endValueChange
FY2015Dec 31, 2015$93.11K–

More MariMed figures

See a number that looks wrong?